Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire
Neuropsychopharmacology Reports · 2026
DOI: 10.1002/npr2.70164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2026. Verfasst von Futaba Umemura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan. Hauptthemen laut MEDLINE: Hallucinogens, Mysticism, Patient Reported Outcome Measures. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science, Multilayered Stress Diseases.
Abstract (Originalsprache)
Introduction
Interest in therapeutic applications of psychedelics has recently resurged. Mystical‐type and challenging experiences that are elicited by psychedelics are commonly assessed using the 30‐item Mystical Experience Questionnaire (MEQ‐30) and the 26‐item Challenging Experience Questionnaire (CEQ), respectively. The brief 4‐item MEQ (MEQ‐4) and 7‐item CEQ (CEQ‐7) may reduce respondent burden, but Japanese versions have not yet been developed. This study developed Japanese versions of the MEQ‐4 and CEQ‐7.
Methods
In translating the MEQ‐4 and CEQ‐7, our procedures were informed by the recommendations of the “Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient‐Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation.” Separately, experts in psychedelics reviewed semantic nuances and the naturalness and appropriateness of the Japanese wording. Cognitive debriefing was not conducted because recruiting an appropriate Japanese‐speaking sample with psychedelic experience was not feasible.
Results
The final, approved back‐translated versions of the MEQ‐4 and CEQ‐7 were developed, and the authorized Japanese versions of the MEQ‐4 and CEQ‐7 were established.
Conclusions
In the present study, Japanese versions of the MEQ‐4 and CEQ‐7 were developed, enabling more rapid and efficient assessments of mystical and challenging experiences among Japanese speakers. Future studies should evaluate their comprehensibility, interpretability, cultural appropriateness, reliability, and validity in Japanese‐speaking samples.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
- Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
- Department of Neuropsychopharmacology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
- Kahlert Institute for Addiction Medicine, University of Maryland, School of Medicine, Baltimore, Maryland, USA.
- Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Futaba Umemura, Justin C Strickland, Albert Garcia-Romeu, Matthew W Johnson, Kazutaka Ikeda
Förderung
- Japan Society for the Promotion of Science
- Multilayered Stress Diseases
Zitieren
APA
Umemura, F., Kotajima-Murakami, H., Strickland, J. C., Garcia-Romeu, A., Johnson, M. W., & Ikeda, K. (2026). Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.70164
Vancouver
Umemura F, Kotajima-Murakami H, Strickland JC, Garcia-Romeu A, Johnson MW, Ikeda K. Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire. Neuropsychopharmacology Reports. 2026. doi:10.1002/npr2.70164
BibTeX
@article{Umemura2026,
author = {Umemura, Futaba and Kotajima-Murakami, Hiroko and Strickland, Justin C and Garcia-Romeu, Albert and Johnson, Matthew W and Ikeda, Kazutaka},
title = {Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire},
journal = {Neuropsychopharmacology Reports},
year = {2026},
doi = {10.1002/npr2.70164}
}
EUVIMED